TELLABS, INC. Los Angeles, California--(Newsfile Corp. - September 17, 2015) - An exciting array of new products will be unveiled today by True Leaf Medicine International Ltd., (CSE: MJ) (FSE: TLA) ("True Leaf" or the "company") at the Cannabis World Conference and Business Expo in LA.
They're an innovative line of chews for dogs featuring hemp and other plant-based active ingredients to provide joint, calming and antioxidant support for dogs.
Trio of products to debut at Cannabis World in LA Thursday
To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/3826/17283_truele1enhanced.jpg
These first TrueLeafPet products are designed to be incorporated into a daily functional chew for dogs of all ages:
TrueLove™ 'Antioxidant Support' provides 500 milligrams of hemp, polyphenols from green tea, pomegranate and blueberries and DHA from whole-cell algae.
TrueSpirit™ 'Joint Support' provides 500 milligrams of hemp, 250 milligrams of plant-based non-GMO glucosamine HCL and 15mg of curcuminoids from turmeric root extract.
TrueCalm™'Calming Support' provides 500 milligrams of hemp with a precise combination of the active ingredient 'L-theanine' and calming herbs like chamomile, passionflower and lemon balm.
The products will be available in pet stores across North America this fall at a retail price of $14.99 or $.38 per chew. For more information, please email info@trueleaf.com or phone 1.778.475.5323
True Leaf invites attendees at the Cannabis World Conference and Business Expo to booth 316 to meet CEO Darcy Bomford and see True Love, True Spirit and True Calm for themselves at the Expo on Thursday and Friday, September 17 and 18, at the Los Angeles Convention Centre.
About True Leaf International Ltd:
True Leaf Medicine International Ltd. is entering the $60 billion pet industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada and the US. The company has also filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance.
Media Contact:
Paul Sullivan
BreakThrough Communications
O: 604-685-4742 M: 604-603-7358
p.sullivan@breakthroughpr.com
